NASDAQ
Medexus Pharmaceuticals Inc. (MEDXF) has a free cash flow growth of 134.59% as of Friday, May 29, 2026. This represents a 1094.30% increase compared to its 12-month average of 11.27%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.